Radiofrequency ablation of metastases from osteosarcoma in patients under 25 years: The SCFE experience

Pediatric Hematology and Oncology

Volumn 32, Issue 1, 2015, Pages 41-49

  Saumet, Laure ^a   Deschamps, F ^b   Marec Berard, P ^c   Gaspar, N ^b   Corradini, N ^d   Petit, P ^e   Sirvent, N ^a   Brugieres L ^b  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Institut d'Hemato Oncologie Pediatrique   (France)

^d Hopital Mere Enfant CHU de Nantes   (France)

^e TIMONE HOSPITAL   (France)

Author keywords

AYA; Bone metastases; Lung metastases; Osteosarcoma; Radiofrequency ablation

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; BONE METASTASIS; BURN; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPUTED TOMOGRAPHY SCANNER; DRUG MEGADOSE; FEMALE; FOLLOW UP; FRACTURE; GROUPS BY AGE; HEMOPTYSIS; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; PNEUMOTHORAX; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; SOFT TISSUE INFECTION; ADVERSE EFFECTS; BONE NEOPLASMS; CATHETER ABLATION; CLINICAL TRIAL; LUNG NEOPLASMS; METASTASIS; MULTICENTER STUDY; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SECONDARY;

ADOLESCENT; ADULT; BONE NEOPLASMS; CATHETER ABLATION; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; OSTEOSARCOMA; RETROSPECTIVE STUDIES;

EID: 84921819340     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2014.926469     Document Type: Article

References (33)

1. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg. 2006;30(1):177-183.
2. de Baere T, Palussiere J, Auperin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240(2):587-596.
3. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9(7):621-628.
4. Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer. 2007;109(7):1397-1405.
5. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-termsafety and efficacy in 153 patients. Radiology. 2007;243(1):268-275.
6. Steinke K, Sewell PE, Dupuy D, et al. Pulmonary radiofrequency ablation-an international study survey. Anticancer Res. 2004;24(1):339-343.
7. Motamedi D, Learch TJ, Ishimitsu DN, et al. Thermal ablation of osteoid osteoma: overview and step-by-step guide. Radiographics. 2009;29(7):2127-2141.
8. Rosenthal DI, Hornicek FJ, Torriani M, et al. Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology. 2003;229(1):171-175.
9. Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology. 2002:224(1):87-97.
10. Clarencon F, Jean B, Pham HP, et al. Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastases. Skeletal Radiol. 2011;42(1):25-36.
11. Dupuy DE, Liu D, Hartfeil D, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer. 2010;116(4):989-997.
12. Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22(2):300-306.
13. Thanos L, Mylona S, Galani P, et al. Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol. 2008;37(3):189-194.
14. van Laarhoven S, van Baren R, Tamminga RY, de Jong KP. Radiofrequency ablation in the treatment of liver tumors in children. J Pediatr Surg. 2012;47(3):e7-e12.
15. Sugito K, Kusafuka T, Hoshino M, et al. Application of radiofrequency ablation for giant solid pseudopapillary tumor of the pancreas. Pediatr Int. 2010;52(1):e29-e31.
16. Ilaslan H, Schils J, Joyce M, et al. Radiofrequency ablation: another treatment option for local control of desmoid tumors. Skeletal Radiol. 2010;39(2):169-173.
17. Hoffer FA, Daw NC, Xiong X, et al. A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumors. Cancer. 2009;115(6):1328-1337.
18. Bielack SS, Kempf-Bielack B, Branscheid D, et al. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. J Clin Oncol. 2009;27(4):557-565.
19. Harting MT, Blakely ML, Jaffe N, et al. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma. J Pediatr Surg. 2006;41(1):194-199.
20. Briccoli A, Rocca M, Salone M, et al. Resection of recurrent pulmonary metastases in patients with osteosarcoma. Cancer. 2005;104(8):1721-1725.
21. Letourneau PA, Xiao L, Harting MT, et al. Location of pulmonary metastasis in pediatric osteosarcoma is predictive of outcome. J Pediatr Surg. 2011;46(7):1333-1337.
22. Meyer WH, Schell MJ, Kumar AP, et al. Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival. Cancer. 1987;59(2):374-379.
23. Diemel KD, Klippe HJ, and Branseheid D. Pulmonary metastasetomy for osteosarcoma: is it justified? Recent Results Cancer Res. 2009;179:183-208.
24. Karplus G, McCarville MB, Smeltzer MP, et al. Should contralateral exploratory thoracotomy be advocated for children with osteosarcoma and early unilateral pulmonary metastases? J Pediatr Surg. 2009;44(4):665-671.
25. Okuma T, Matsuoka T, Yamamoto A, et al. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution. Cardiovasc Intervent Radiol. 2010;33(4):787-793.
26. Kashima M, Yamakado K, Takaki H, et al., Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences. AJR Am J Roentgenol. 2011;197(4):W576-W580.
27. Palussiere J, Marcet B, Descat E, et al. Lung tumors treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up. Cardiovasc Intervent Radiol. 2011;34(5):989-997.
28. Rybak LD, Rosenthal D, Wittig JC. Chondroblastoma: radiofrequency ablation-alternative to surgical resection in selected cases. Radiology. 2009;251(2):599-604.
29. Albisinni U, Rimondi E, Malaguti MC, Ciminari R. Percutaneous radiofrequency ablation of chordoma. AJR Am J Roentgenol. 2004;183(1):245; author reply 245-246.
30. Neeman Z, Patti JW, Wood BJ. Percutaneous radiofrequency ablation of chordoma. AJR Am J Roentgenol. 2002;179(5):1330-1332.
31. Rosenthal D, Callstrom MR. Critical review and state of the art in interventional oncology: benign and metastatic disease involving bone. Radiology. 2012;262(3):765-780.
32. Le Deley MC, Guinebretiere JM, Gentet JC, et al., Societe Francaise d'Oncologie Pediatrique (SFOP). SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. Eur J Cancer. 2007;43(4):752-761.
33. Sarcome 09/0603: EudraCT # 2006-00337727 promoted by UNICANCER